MAPT and Mental deterioration: These findings are consistent with well-established associations between CSF biomarkers and cognition—namely, that lower CSF Aβ42 and higher tau levels are linked to poorer cognitive performance—and suggest that P-tau181 may be sensitive to earlier cognitive decline [21].